Generics 6

Originals

Biosimilars

Medical devices

Nutraceuticals

Filters

Etoricoxib manufacturers

6 products found

Filters

Filters

Filters , active

Country of origin : Bangladesh

Clear all

6 products found

etoricoxib

Tablets 60 mg, 90 mg, 120 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Bangladesh
GMP approvals
WHO
Manufacturer #21340

The CTD dossier owner and manufacturer is a leading conglomerate with a diverse range of business operations across multiple industries. The website is structured to provide detailed financial information through sections like “Annual Report,” “Quarterly Report,” and “Price Sensitive Information,” which include links to various reports from recent years and updates on financial performance, such as notices about bond issuances. The company operates in several key sectors, including textiles, pharmaceuticals, personal protective equipment (PPE), ceramics, information and communication technology (ICT), real estate and trading, media, financial services, energy, and travel and tourism. As the largest entity within its group, the company plays a significant role in driving economic activities and growth across these industries, reflecting its strong market presence and commitment to diversified business interests.

Manufacturer usually replies in 44 days

etoricoxib

Tablets, film coated 60 mg, 90 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Bangladesh
GMP approvals
Bangladesh
Manufacturer #21469

Established in 1984, this manufacturer is a certified CTD dossier owner and manufacturer, offering over 150 pharmaceutical products across local and international markets. As a GMP manufacturer, it operates an ISO 9001:2015 certified facility in Dhaka, Bangladesh, with ideal machinery and skilled professionals. With a workforce of approximately 500, this CTD dossier owner and manufacturer ensures consistent quality through GMP-compliant production lines, reinforcing its global reach as a GMP manufacturer and CTD dossier owner and manufacturer.

 

etoricoxib

Tablets 60 mg, 90 mg, 120 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Bangladesh
GMP approvals
WHO
Manufacturer #21084

This CTD dossier owner and manufacturer provides a detailed list of medications, including both generic and sometimes brand names, each categorized by their therapeutic class, such as antihypertensives, antibiotics, analgesics, and vitamins. This classification helps medical professionals—like doctors, pharmacists, and nurses—quickly understand a drug’s purpose and its potential interactions with other medications, while also providing patients with insights into how their prescribed medications function. Researchers can leverage this data to examine medication use trends or to identify gaps in treatment options for certain conditions. This data can be further utilized by creating a searchable database, visualizing relationships between medications through charts or graphs, and comparing drugs within the same therapeutic class to analyze their uses, side effects, and dosage forms.

Manufacturer usually replies in 13 days

Want to see all 6 products?

Subscribe today to benefit from:

  • Streamlined product sourcing - the leading CTD dossiers database focused on finished dosage formulations

  • Direct negotiations - connect and negotiate directly with manufacturers without any brokerage fee

  • Increased profitability - secure the best commercial terms for your business by comparing offers from several manufacturers

Request Subscription

What is the Etoricoxib drug?

Etoricoxib is a selective COX-2 inhibitor. Etoricoxib is used to treat rheumatoid arthritis, psoriatic arthritis, osteoarthritis, ankylosing spondylitis, chronic low back pain, acute pain, and gout. Etoricoxib helps to reduce the pain and inflammation in the joints and muscles of people. McOLSON Research Laboratories developed Etoricoxib; it was patented in 1996 and approved for medical use in 2002. Etoricoxib is a globally found drug; it is in use in more than eighty countries. However, in the US, the FDA has required some more safety and efficacy data for etoricoxib before it will issue approval. The etoricoxib approval indications can change by country. In the UK, Etoricoxib is authorized for the short term treatment of moderate pain after dental surgery of adults.

Etoricoxib manufacturers and wholesalers:

Etoricoxib has many brand names; the most known is Gencox. Some of the others are Algix and Tauxib in Italy, Arcox, Berrica, and Starcox in Pakistan, Arcoxia in Spain, Egypt, Saudi Arabia, Sweden, Finland, Norway, Estonia, Germany, Greece, Lithuania, Luxembourg, Chile, China, Hong Kong, Hungary, Indonesia, Ireland, Israel, and more. Torrent Pharma (UK) Ltd is the Marketing Authorisation Holder and Manufacturer. Etoricoxib suppliers market it in the form of film-coated tablets of 30 mg, 60 mg, 90 mg, and 120 mg.

Etoricoxib for sales:

Etoricoxib prices can change depending on the country. In Canada for a 90 mg film-coated tablet, Etoricoxib costs from $0.69 to $0.77 per unit. In France, for a 60 me film-coated tablet, Etoricoxib costs about 0.31€ per unit, and in the UK, for a 30 mg film-coated tablet, Etoricoxib costs about £0.47.
As Etoricoxib is a globally found drug, you may encounter fraudulent online websites that will want to sell Etoricoxib with some risks for you and your clients. By using Pipelinepharma B2B marketplace, you avoid time-consuming sourcing, and you directly find qualified sellers of Etoricoxib. Those manufacturers have been through quality control procedures to assure the Etoricoxib distributors they were qualified partners. On the online platform, Etoricoxib is mostly available from the EU, India, Israel, Canada, and Argentina. Thanks to the intuitive online marketplace, you will find Etoricoxib and many other drugs quickly and efficiently. Placing an order or an inquiry has never been easier than with Pipelinepharma. Let us connect you with Etoricoxib manufacturers from wherever in the world.

How to use Etoricoxib drugs?

To treat osteoarthritis with Etoricoxib, the recommended dose for an adult patient is 30 mg once a day; it can be increased to a maximum of 60 mg once a day if needed. To treat Rheumatoid arthritis and Ankylosing spondylitis, an adult patient should take 60 mg once a day, increased to a maximum of 90 mg once a day if needed.
Following an Etoricoxib treatment can cause some side effects. The most common ones include stomach pain, dry socket, swelling of the legs and, or feet due to fluid retention, dizziness, headache, palpitations, irregular heart rhythm (arrhythmia), increased blood pressure.

Interested in Subscription?

Please fill out form and send us your specific requirements, and we will get back to you as soon as possible